Reduction of Interlukin-8 by Peptides from Digestive Enzyme Hydrolysis of Hen Egg Lysozyme

  • Lee, MooHa (Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University) ;
  • Young, Denise (Department of Food Science, University of Guelph) ;
  • Mine, Yoshinori (Department of Food Science, University of Guelph) ;
  • Jo, CheoRun (Department of Animal Science and Biotechnology, Chungnam National University)
  • Published : 2009.06.30

Abstract

Lysozyme was treated with digestive enzymes and the production of interleukin 8 (IL-8) was measured in Caco-2 cell with the peptides from lysozyme upon stimulating with lipopolysaccharide (LPS) to investigate the overall anti-inflammatory activity of lysozyme when it is in digestive tracts. Lysozyme reduced IL-8 production, and the peptides from pepsin hydrolysis of lysozyme had the similar effect. The products of trypsin digestion of lysozyme had no effect on the reduction of IL-8 production while those of pepsin-trypsin hydrolysis did. The effectiveness of lowering IL-8 production was not different by time of the peptide addition. When Caco-2 cells were pre-incubated with peptides for 24 hr, the reduction effects were observed from the peptides from pepsin hydrolysis, indicating that some of the peptides are still remaining in the cells. Therefore, it can be concluded that the IL-8 reduction effect of lysozyme against LPS still remained even after the pepsin and trypsin hydrolysis.

Keywords

References

  1. Kitts D, Weiler K. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr. Pharm. Design 9: 1309-1323 (2003) https://doi.org/10.2174/1381612033454883
  2. Kovacs-Nolan J, Phillips M, Mine Y. Advances in the value of eggs and egg components for human health. J. Agr. Food Chem. 53: 8421-8431 (2005) https://doi.org/10.1021/jf050964f
  3. Pihlanto A, Korhonen H. Bioactive peptides and proteins. Adv. Food Nutr. Res. 47: 175-276 (2003) https://doi.org/10.1016/S1043-4526(03)47004-6
  4. Guimont C, Marchall E, Girardet JM, Linden G. Biologically active factors in bovine milk and dairy byproducts: Influence on cell culture. Crit. Rev. Food Sci. 37: 393-410 (1997) https://doi.org/10.1080/10408399709527780
  5. Ahn DU, Lee SH, Singam H, Lee EJ, Kim JC. Sequential separation of main components from chicken egg yolk. Food Sci. Biotechnol. 15: 189-195 (2006)
  6. Lee EY, Woo GJ, Par J. Separation of antimicrobial hen egg white lysozyme using ultrafilatration. Food Sci. Biotechnol. 12: 371-375 (2003)
  7. Anton M, Nau F, Nys Y. Bioactive egg components and their potential uses. Worlds Poultry Sci. J. 62: 429-438 (2006) https://doi.org/10.1017/S004393390600105X
  8. Korhonen H, Pihlanto A. Food-derived bioactive peptidesopportunities for designing future foods. Curr. Pharm. Design 9: 1297-1308 (2003) https://doi.org/10.2174/1381612033454892
  9. Vercruysse L, Van Camp J, Smagghe G. ACE inhibitory peptides derived from enzymatic hydrolysates of animal muscle protein: A review. J. Agr. Food Chem. 53: 8106-8115 (2005) https://doi.org/10.1021/jf0508908
  10. Jiang B, Mine Y. Preparation of novel functional oligophosphopeptides from hen yolk phosvitin. J. Agr. Food Chem. 48: 990-994 (2000) https://doi.org/10.1021/jf990600l
  11. Watanabe K, Tsuge Y, Shimoyamada M, Ogama N, Ebina T. Antitumor effects of pronase-treated fragments, glycopeptides, from ovomucin in hen egg white in a double grafted tumor system. J. Agr. Food Chem. 46: 3033-3038 (1998) https://doi.org/10.1021/jf9800615
  12. Miguel M, Aleixandre MA, Ramos M, Lopez-Fandino R. Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin. J. Agr. Food Chem. 54: 726-731 (2006) https://doi.org/10.1021/jf051101p
  13. Miguel M, Aleixandre A. Antihypertensive peptides derived from egg proteins. J. Nutr. 136: 1457-1460 (2006) https://doi.org/10.1093/jn/136.6.1457
  14. Xu M, Shangguan X, Wang W, Chen J. Antioxidative activity of hen egg ovalbumin hydrolysates. Asia Pac. J. Clin. Nutr. 16: 178-182 (2007)
  15. Ibrahim HR, Sugimoto Y, Aoki T. Ovotransferrin antimicrobial peptide (OTAP-92) kills bacteria through a membrane damage mechanism. Biochim. Biophy. Acta 1523: 196-205 (2000) https://doi.org/10.1016/S0304-4165(00)00122-7
  16. Mine Y, Ma F, Lauriau S. Antimicrobial peptides released by enzymatic hydrolysis of hen egg white lysozyme. J. Agr. Food Chem. 52: 1088-1094 (2004) https://doi.org/10.1021/jf0345752
  17. Biziulevicius GA. Where do the immunostimulatory effects of oral proteolytic enzymes ('systemic enzyme therapy') come from? Microbial proteolysis as a possible starting point. Med. Hypotheses 67: 1386-1388 (2006) https://doi.org/10.1016/j.mehy.2006.05.051
  18. Shimizu M. Food-derived peptides and intestinal functions. Biofactors 21: 43-47 (2004) https://doi.org/10.1002/biof.552210109
  19. Jolles P, Jolles J. What's new in lysozyme research? Mol. Cell. Biochem. 63: 165-189 (1984) https://doi.org/10.1007/BF00285225
  20. Ogundele MO. A novel anti-inflammatory activity of lysozyme:modulation of serum complement activation. Mediat. Inflamm. 7: 363-365 (1998) https://doi.org/10.1080/09629359890893
  21. Gordon LI, Douglas SD, Kay NE, Yamada O, Osserman EF, Jacob HS. Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J. Clin. Invest. 64: 226-232 (1979) https://doi.org/10.1172/JCI109443
  22. Haas M, Moalenaar F, Meijer DKF, De Jong PE, De Zeeuw D. Renal targeting of a non-steroidal anti-inflammatory drug: Effects on renal prostaglandin synthesis in the rats. Clin. Sci. 95: 603-609 (1998) https://doi.org/10.1042/CS19980188
  23. Hung CR. Effect of lysozyme chloride on betel quid chewing aggravated gastric oxidative stress and hemorrhagic ulcer in diabetic rats. World J. Gastroenterol. 11: 5853-5858 (2005)
  24. Sato M, Oe H, Nakano M, Kawasaki H, Hirayama C. A random contolled study of the prophylactic effect of lysozyme chloride on post-transfusion hepatitis. Hepato-Gastroenterol. 28: 135-138 (1981)
  25. Huang Y, Li N, Liboni K, Neu J. Glutamin decreases lipopolysaccharide-induced IL-8 production in Caco-2 cells through a non-NF-kB p50 mechanism. Cytokine 22: 77-83 (2003) https://doi.org/10.1016/S1043-4666(03)00115-7
  26. SAS. The SAS System for Windows (Release 9.1). SAS Institute, Inc., Cary, NC, USA (2002-2003)
  27. Ohno N, Morrison DC. Lipopolysaccharide interactions with lysozyme differentially affect lipopolysaccharide immunostimulatory. Eur. J. Biochem. 186: 629-636 (1989) https://doi.org/10.1111/j.1432-1033.1989.tb15253.x
  28. Takada K, Ohno N, Yadomae T. Lysozyme regulates LPS-induced interleukin-6 release in mice. Circ. Shock 44: 169-174 (1994)
  29. Takada K, Ohno N, Yadomae T. Detoxification of lipopolysaccharide (LPS) by egg white lysozyme. FEMS Immunol. Med. Mic. 9: 255-264 (1994) https://doi.org/10.1111/j.1574-695X.1994.tb00360.x
  30. Takada K, Ohno N, Yadomae T. Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo. Infect. Immun. 62: 1171-1175 (1994)
  31. Brandenburg K, Koch MHJ, Seydel U. Biophysical characterization of lysozyme binding to LPS Re and lipid A. Eur. J. Biochem. 258: 686-695 (1998) https://doi.org/10.1046/j.1432-1327.1998.2580686.x
  32. Ohno N, Morrison DC. Lipopolysaccharide interactions with lysozyme. Binding of lipopolysaccharide to lysozyme and inhibition of lysozyme enzymatic activity. J. Biol. Chem. 264: 4434-4441 (1989)
  33. Takenaka A, Takenaka O, Mizota T, Shibata K, Inada Y. Sodium trichloro- acetate as a denaturation reagent for proteins. J. Biochem. 70: 63-73 (1971) https://doi.org/10.1093/oxfordjournals.jbchem.a129627
  34. Augusto LA, Li J, Synguelakis M, Johansson J, Chaby R. Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J. Biol. Chem. 28: 23484-23492 (2002) https://doi.org/10.1074/jbc.M111925200
  35. Kanayama N, Kajiwara Y, Goto J, Maradny EL, Maehara K, Andou K, Terao T. Inactivation of interleukin-8 by aminopeptidase N(CD13). J. Leukocyte Biol. 57: 129-134 (1995) https://doi.org/10.1002/jlb.57.1.129
  36. Leavell KJ, Peterson MW, Gross TJ. Human neutrophil elastase abolishes interleukin-8 chemotactic activity. J. Leukocyte Biol. 61: 361-366 (1997) https://doi.org/10.1002/jlb.61.3.361
  37. Yoshikawa M, Fujita H, Matoba N, Takenaka Y, Yamamoto T, Yamauchi R, Tsuruki H, Takahata K. Bioactive peptides derived from food proteins preventing lifestyle-related diseases. Biofactors 12: 143-146 (2000) https://doi.org/10.1002/biof.5520120122
  38. Radons J, Biewusch U, Grassel S, Geuze HJ, Hasilik A. Distinctive inhibition of the lysosomal targeting of lysozyme and cathepsin D by drugs affecting pH gradients and protein kinase C. Biochem. J. 302: 581-586 (1994) https://doi.org/10.1042/bj3020581